Closing Bell: Knight Therapeutics Inc down on Thursday (GUD)

Today, shares of Knight Therapeutics Inc opened at $5.65 and closed at $5.67. It traded at a low of $5.58 to a high of $5.70.

The price eased -0.87 percent from the previous day's close of $5.72.

During the day across North America, the TSX Composite closed -1.68% at 22723.21, the S&P 500 closed 1.58% at 5522.30, the Dow Jones Industrial Average closed 0.24% at 40842.79 and the Nasdaq Composite closed 2.64% at 17599.40.

Knight Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker GUD.

Trading volume was 35,057 on 218 total trades, with an average volume of 45,308 over 5 days.

The TSX overall saw 907 price advancers against 4,327 declines and 72 unchanged.

During the prior 52 weeks, GUD.TO has traded as high as $6.22 (May 15,2024) and low as $4.35 (October 23,2023). Moreover, in the last 52 weeks, Knight Therapeutics Inc's shares have raised 17.39%, while they have advanced 9.25% since the start of 2024.

Following today's trading, Knight Therapeutics Inc has a market capitalization of $579.87 million on a float of 101,376 shares outstanding. Its annual EPS is $-0.16.

Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.

Knight Therapeutics Inc is holding an average recommendation of "Moderate Buy" from 4.00 analysts according to Zacks. Currently, there are 3 buy ratings and 1 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..